JPH11100324A - Composition for treating acne - Google Patents
Composition for treating acneInfo
- Publication number
- JPH11100324A JPH11100324A JP9281487A JP28148797A JPH11100324A JP H11100324 A JPH11100324 A JP H11100324A JP 9281487 A JP9281487 A JP 9281487A JP 28148797 A JP28148797 A JP 28148797A JP H11100324 A JPH11100324 A JP H11100324A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- acne
- treating acne
- licorice
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
(57)【要約】
【解決手段】 甘草から抽出された油溶性抽出物と、角
質剥離剤及び/又は抗炎症剤とを併用してなることを特
徴とするニキビ治療用組成物。
【効果】 本発明によれば、ステロイド剤が有するよう
な副作用がなく、優れたニキビ治療乃至予防効果を有す
るニキビ治療用組成物を提供することができる。(57) Abstract: A composition for treating acne, comprising a combination of an oil-soluble extract extracted from licorice and a keratolytic agent and / or an anti-inflammatory agent. EFFECTS OF THE INVENTION According to the present invention, it is possible to provide a composition for treating acne, which does not have the side effects of steroids and has an excellent acne treatment or prevention effect.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、優れたニキビ治療
乃至予防効果を有するニキビ治療用組成物に関する。TECHNICAL FIELD The present invention relates to a composition for treating acne having an excellent effect of treating or preventing acne.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】ニキビ
の発症機序については未だ不明の点が多いが、皮脂分泌
亢進、毛包角化促進、細菌増殖、毛包壁の炎症などが主
な要因として考えられている。従来よりニキビの治療に
は、これらの要因に対応して抗菌剤、抗炎症剤、皮脂分
泌抑制剤、角質剥離剤を配合したクリーム、軟膏などが
一般に使用されている。しかし、既存の各種薬剤を配合
したニキビ治療薬には種々の欠点があった。例えば、抗
菌剤にはグルコン酸クロルヘキシジン、塩化ベンザルコ
ニウムなどがあるが、皮膚を極端に荒らすなどの刺激が
強く、実際の使用では効果を充分に発揮できない。更
に、皮脂分泌抑制剤として女性ホルモン類が使われる
が、ホルモン剤が引き起こす副作用には大きな問題があ
る。2. Description of the Related Art Although there are still many unclear points about the mechanism of acne development, the main factors are the increase in sebum secretion, promotion of follicle keratinization, bacterial proliferation, and inflammation of the hair follicle wall. Is considered as a factor. Conventionally, for treatment of acne, creams, ointments, and the like containing an antibacterial agent, an anti-inflammatory agent, a sebum secretion inhibitor, and a keratin exfoliant have been generally used in response to these factors. However, there are various drawbacks in acne treatment drugs containing various existing drugs. For example, antibacterial agents include chlorhexidine gluconate, benzalkonium chloride, and the like, but they are extremely irritating such as extremely roughening of the skin, and cannot be sufficiently effective in actual use. Furthermore, female hormones are used as sebum secretion inhibitors, but there are serious problems with the side effects caused by hormonal agents.
【0003】また、作用点の違う薬剤を併用して、相乗
的にニキビ治療効果を発揮させることが考えられるが、
満足できる相乗効果が得られなかったり、副作用が相乗
的に発現したりして、ニキビ治療に効果的な薬剤の組み
合わせは未だ得られていない。[0003] It is conceivable that a combination of drugs having different action points may exert a synergistic effect on acne treatment.
No satisfactory synergistic effect has been obtained, or side effects have been synergistically developed, and no effective drug combination for acne treatment has yet been obtained.
【0004】従って、本発明の目的は、刺激その他の副
作用を有さず、かつニキビを効果的に治療、予防できる
ニキビ治療用組成物を提供することにある。Accordingly, it is an object of the present invention to provide a composition for treating acne which has no irritation or other side effects and which can effectively treat and prevent acne.
【0005】[0005]
【課題を解決するための手段及び発明の実施の形態】本
発明者らは、上記目的を達成するため鋭意検討を行った
結果、甘草から抽出された油溶性抽出物に、角質剥離剤
及び/又は抗炎症剤を組み合せることにより、皮膚に対
する刺激やステロイド剤が有するような副作用がなく、
優れたニキビ治療乃至予防効果が得られることを知見
し、本発明を完成するに至った。Means for Solving the Problems and Embodiments of the Invention The present inventors have conducted intensive studies to achieve the above object, and as a result, the oil-soluble extract extracted from licorice was added to the exfoliating agent and / or Or by combining anti-inflammatory agents, there is no side effects such as skin irritation and steroids,
The inventors have found that excellent acne treatment or prevention effects can be obtained, and have completed the present invention.
【0006】なお従来、甘草から抽出された油溶性抽出
物を美白剤の有効成分として使用することは知られてい
る(特開平5−201847号、同6−256152
号、同6−271442号、同6−271453号、同
8−12518号公報等)が、この甘草からの油溶性抽
出物と角質剥離剤、抗炎症剤とを併用することが顕著な
ニキビ治療効果を与えることは、本発明者らによる新知
見である。[0006] Conventionally, it has been known to use an oil-soluble extract extracted from licorice as an active ingredient of a whitening agent (JP-A-5-201847 and JP-A-6-256152).
No. 6-271442, No. 6-271453, No. 8-12518, etc.), in which it is remarkable that an oil-soluble extract from licorice is used in combination with a keratolytic agent and an anti-inflammatory agent. Giving an effect is a new finding by the present inventors.
【0007】以下、本発明につき更に詳しく説明する。
本発明のニキビ治療用組成物は、(A)甘草から抽出さ
れた油溶性抽出物と、(B)角質剥離剤及び(C)抗炎
症剤の1種又は2種以上とを有効成分とする。Hereinafter, the present invention will be described in more detail.
The composition for treating acne of the present invention comprises (A) an oil-soluble extract extracted from licorice, and (B) one or more of a keratolytic agent and (C) an anti-inflammatory agent as active ingredients. .
【0008】本発明のニキビ治療用組成物に配合される
甘草から抽出された油溶性抽出物(A)は、ナンキンカ
ンゾウ(Glycyrrhiza glabra)、ウ
ラルカンゾウ(Glycyrrhiza uralen
sis)、シナカンゾウ(Glycyrrhiza e
chnata)、イヌカンゾウ(Glycyrrhiz
a pallidiflra)、又は同属植物の根を乾
燥あるいはそのまま粉砕した物を溶媒抽出することによ
り得ることができる。[0008] The oil-soluble extract (A) extracted from licorice in the composition for treating acne of the present invention is composed of Glycyrrhiza glabra and Glycyrrhiza uralen.
sis), Glycyrrhiza e
chnata), Glycyrrhiz
a pallidifra) or a root of a plant belonging to the same genus is dried or ground as it is and can be obtained by solvent extraction.
【0009】抽出溶媒としては、メタノール、エタノー
ル、ブタノール等のアルコール類、ヘキサン、ヘプタ
ン、シクロヘキサン等の脂肪族又は脂環式炭化水素類、
酢酸エチル等のエステル、アセトン等のケトン又はエー
テル類などが挙げられ、これらの1種を単独で又は2種
以上を組み合せて用いることができ、通常3〜70℃程
度の温度で抽出処理することができる。得られた抽出液
は、そのまま用いても、あるいは希釈液としたり、濃縮
乾燥することによって乾燥粉末物としたり、ペースト状
に調製して用いてもよい。また、抽出液より有効成分を
分離精製して用いることもできる。Examples of the extraction solvent include alcohols such as methanol, ethanol and butanol, aliphatic and alicyclic hydrocarbons such as hexane, heptane and cyclohexane.
Examples thereof include esters such as ethyl acetate, ketones such as acetone, and ethers, and one of these can be used alone or in combination of two or more. Usually, extraction treatment is performed at a temperature of about 3 to 70 ° C. Can be. The obtained extract may be used as it is, or may be used as a diluent, a dried powder by concentrating and drying, or prepared in a paste form. Further, the active ingredient can be separated and purified from the extract and used.
【0010】この場合、抽出条件はこれに限定されるも
のではないが、無水エタノールで抽出後、濃縮し、それ
からさらに酢酸エチルで抽出した後、減圧乾燥して粉末
エキスとしたものを用いることが好ましい。In this case, the extraction conditions are not limited to those described above. However, after extraction with absolute ethanol, concentration, extraction with ethyl acetate, and drying under reduced pressure to obtain a powder extract may be used. preferable.
【0011】分離精製は溶媒での抽出物をカラムクロマ
トグラフィー、液体クロマトグラフィーで精製すること
ができる。例えば、ナンキンカンゾウ、ウラルカンゾ
ウ、シナカンゾウ、イヌカンゾウからのグラブリジンの
分離精製は、上述の粉末乾燥エキスを順相シリカゲルカ
ラムクロマトグラフィー及び逆相シリカゲルカラムクロ
マトグラフィーにより処理した後、ヘキサン−ベンゼン
混合溶媒系から結晶化する方法で行うことができる。抽
出物の色及びにおいの除去については、活性炭もしくは
吸着樹脂を用いて行うことができる。[0011] Separation and purification can be achieved by purifying an extract with a solvent by column chromatography or liquid chromatography. For example, separation and purification of glabridine from Nankin licorice, Uralkanzo, Chinese licorice, and dog liquorice, the above-mentioned powdery dried extract is processed by normal-phase silica gel column chromatography and reverse-phase silica gel column chromatography, and then from a hexane-benzene mixed solvent system. Crystallization can be performed. The color and odor of the extract can be removed using activated carbon or an adsorption resin.
【0012】上記甘草から抽出された油溶性抽出物の配
合量は、本発明におけるニキビ治療用組成物全体に対し
0.005〜10重量%、好ましくは0.05〜1重量
%である。配合量が0.005重量%未満の時には効果
が不十分であり、また、10重量%を超える場合は製剤
への配合が困難であることから、10重量%を超えない
ことが望ましい。The amount of the oil-soluble extract extracted from the licorice is 0.005 to 10% by weight, preferably 0.05 to 1% by weight, based on the total composition for treating acne in the present invention. When the amount is less than 0.005% by weight, the effect is insufficient. When the amount exceeds 10% by weight, it is difficult to incorporate the compound into a preparation.
【0013】角質剥離剤(B)とは、表皮剥脱促進剤の
ことであり、角質増殖、上皮肥厚やそれに伴う皮膚病の
治療、毛髪除去、皮膚表面の清掃の目的に使用されるも
のである。[0013] The exfoliating agent (B) is an exfoliating accelerator, and is used for the purpose of treating hyperkeratosis, epithelial hyperplasia and associated skin diseases, removing hair, and cleaning the skin surface. .
【0014】具体的には、グリコール酸、乳酸、クエン
酸、リンゴ酸、サリチル酸、レゾルシン、硫黄、尿素、
過酸化ベンゾイル、パパイン等が挙げられる。これらの
なかでは、グリコール酸、サリチル酸、レゾルシンが好
ましい。角質剥離剤の配合量は0.01〜5重量%、好
ましくは0.1〜2重量%である。配合量が0.01重
量%未満の時には効果が不十分であり、また、5重量%
を超える場合は製剤への配合が困難であることから、5
重量%を超えないことが望ましい。Specifically, glycolic acid, lactic acid, citric acid, malic acid, salicylic acid, resorcinol, sulfur, urea,
Benzoyl peroxide, papain and the like can be mentioned. Of these, glycolic acid, salicylic acid and resorcin are preferred. The compounding amount of the exfoliating agent is 0.01 to 5% by weight, preferably 0.1 to 2% by weight. When the amount is less than 0.01% by weight, the effect is insufficient.
If it exceeds 5, it is difficult to mix it into the preparation.
It is desirable not to exceed by weight.
【0015】また、抗炎症剤(C)として具体的には、
グリチルリチン酸又はその塩もしくはエステル、グリチ
ルレチン酸又はその塩もしくはエステル、アラントイ
ン、サリチル酸メチル等が挙げられる。抗炎症剤の配合
濃度は0.01〜5重量%、好ましくは0.1〜1重量
%である。5重量%を超えると製剤への配合が困難であ
ることから、5重量%を超えないことが望ましい。Further, specific examples of the anti-inflammatory agent (C) include:
Glycyrrhizic acid or a salt or ester thereof, glycyrrhetinic acid or a salt or ester thereof, allantoin, methyl salicylate and the like can be mentioned. The compounding concentration of the anti-inflammatory agent is 0.01 to 5% by weight, preferably 0.1 to 1% by weight. If it exceeds 5% by weight, it is difficult to mix it into a preparation.
【0016】本発明においては、上記角質剥離剤と抗炎
症剤とを併用して甘草からの油溶性抽出物に配合するこ
とにより、ニキビ治療剤としての効果が高まる。In the present invention, the effect as a remedy for acne is enhanced by combining the above-mentioned exfoliating agent and anti-inflammatory agent into an oil-soluble extract from licorice.
【0017】本発明のニキビ治療用組成物の形態は任意
であり、医薬品、医薬部外品、化粧品、トイレタリー製
品などに広く用いることができる。例えば、油性軟膏
剤、水性軟膏剤、クリーム、美容液、ローション、乳
液、化粧水、パック、石鹸、洗顔剤、メーキャップ、ボ
ディー化粧料などとして用いることができる。The composition for treating acne of the present invention is in any form, and can be widely used for pharmaceuticals, quasi-drugs, cosmetics, toiletries and the like. For example, it can be used as an oily ointment, an aqueous ointment, a cream, a serum, a lotion, an emulsion, a lotion, a pack, a soap, a face wash, a makeup, a body cosmetic, and the like.
【0018】本発明のニキビ治療用組成物中には、上記
必須成分の他に、調製するべき剤において通常配合され
る原料、例えば、界面活性剤、油分、アルコール類、保
湿剤、増粘剤、防腐剤、酸化防止剤、キレート剤、pH
調整剤、香料、色素、紫外線吸収・散乱剤、ビタミン
類、アミノ酸類、水等を配合することができる。In the composition for treating acne of the present invention, in addition to the above-mentioned essential components, raw materials usually blended in the agent to be prepared, for example, surfactants, oils, alcohols, humectants, thickeners , Preservatives, antioxidants, chelating agents, pH
Conditioning agents, fragrances, pigments, ultraviolet absorbing / scattering agents, vitamins, amino acids, water and the like can be added.
【0019】上記必須成分と任意成分を適当に配合する
ことにより、各種の皮膚外用剤、例えば、美容液、クリ
ーム、乳液、軟膏剤、硬膏剤、リニメント剤、ローショ
ン剤、ジェル剤、プラスター、パック、スプレー剤、入
浴剤等の製品形態として用いることができる。By appropriately mixing the above essential components and optional components, various external preparations for skin, for example, serums, creams, emulsions, ointments, plasters, liniments, lotions, gels, plasters, packs , Spraying agent, bathing agent and the like.
【0020】なお、以上のように調製したニキビ治療用
組成物は、その剤型、製品形態によっても相違するが、
1日1回〜数回を患部に適用することによって投与する
ことができる。The composition for treating acne prepared as described above varies depending on its dosage form and product form.
It can be administered once to several times a day by applying it to the affected area.
【0021】[0021]
【発明の効果】本発明によれば、ステロイド剤が有する
ような副作用がなく、優れたニキビ治療乃至予防効果を
有するニキビ治療用組成物を提供することができる。According to the present invention, it is possible to provide a composition for treating acne having excellent acne treatment or prevention effects without the side effects of steroids.
【0022】[0022]
【実施例】次に、実施例と比較例を挙げて本発明を詳細
に説明するが、本発明は以下の実施例に限定されるもの
ではない。下記例で%は重量%である。また、各例の成
分配合量の合計はいずれも100.0%である。なお、
表1〜9における油溶性甘草抽出物は、化粧品種別配合
成分規格収載品である油溶性甘草エキスを用いた。Next, the present invention will be described in detail with reference to examples and comparative examples, but the present invention is not limited to the following examples. In the following examples,% is% by weight. In addition, the total of the compounding amounts of the respective examples is 100.0%. In addition,
As the oil-soluble licorice extract in Tables 1 to 9, an oil-soluble licorice extract, which is a product listed in the specification of the compounding component for each cosmetic variety, was used.
【0023】〔実施例1〜11,比較例1〜3〕表1,
2に示す処方のニキビ治療用組成物を調製した。次に、
ニキビ患者97名を被験者とし、顔面に実施例及び比較
例の美容液を1日数回連続塗布し、1ヶ月後のニキビに
対する治療効果を判定した。判定は、著しく改善(+
+)、改善(+)、不変(±)、悪化(−)の4段階で
行った。判定結果を表1,2に示した。Examples 1 to 11 and Comparative Examples 1 to 3
A composition for treating acne having the formulation shown in No. 2 was prepared. next,
Ninety-seven acne patients were used as test subjects, and the serums of Examples and Comparative Examples were continuously applied to the face several times a day, and the therapeutic effect on acne one month later was determined. Judgment is significantly improved (+
+), Improvement (+), unchanged (±), and deterioration (−). The determination results are shown in Tables 1 and 2.
【0024】実施例1〜11では80%以上の被験者に
治療効果が確認できた。一方、比較例1〜3では60%
未満であり、油溶性甘草抽出物と角質剥離剤及び/又は
抗炎症剤の併用による本発明の優れたニキビ治療効果が
立証された。In Examples 1 to 11, the therapeutic effect was confirmed in more than 80% of the subjects. On the other hand, in Comparative Examples 1 to 3, 60%
And the combined use of the oil-soluble licorice extract and the exfoliating agent and / or anti-inflammatory agent proved the excellent acne treatment effect of the present invention.
【0025】[0025]
【表1】 [Table 1]
【0026】[0026]
【表2】 [Table 2]
【0027】〔実施例12〜32〕表3〜9にニキビ治
療用組成物の処方例を示す。Examples 12 to 32 Tables 3 to 9 show formulation examples of the composition for treating acne.
【0028】[0028]
【表3】 [Table 3]
【0029】[0029]
【表4】 [Table 4]
【0030】[0030]
【表5】 [Table 5]
【0031】[0031]
【表6】 [Table 6]
【0032】[0032]
【表7】 [Table 7]
【0033】[0033]
【表8】 [Table 8]
【0034】[0034]
【表9】 [Table 9]
───────────────────────────────────────────────────── フロントページの続き (72)発明者 袴田 祐輔 東京都墨田区本所1丁目3番7号 ライオ ン株式会社内 ──────────────────────────────────────────────────続 き Continuation of the front page (72) Inventor Yusuke Hakamada 1-7-3 Honjo, Sumida-ku, Tokyo Inside Lion Corporation
Claims (1)
質剥離剤及び/又は抗炎症剤とを併用してなることを特
徴とするニキビ治療用組成物。1. A composition for treating acne, comprising a combination of an oil-soluble extract extracted from licorice and an exfoliant and / or an anti-inflammatory agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9281487A JPH11100324A (en) | 1997-09-29 | 1997-09-29 | Composition for treating acne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9281487A JPH11100324A (en) | 1997-09-29 | 1997-09-29 | Composition for treating acne |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11100324A true JPH11100324A (en) | 1999-04-13 |
Family
ID=17639879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9281487A Pending JPH11100324A (en) | 1997-09-29 | 1997-09-29 | Composition for treating acne |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11100324A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013501779A (en) * | 2009-08-14 | 2013-01-17 | 株式会社アモーレパシフィック | Natural extract-containing composition |
| KR101302225B1 (en) * | 2007-11-22 | 2013-08-30 | 이규민 | Pharmaceutical Composition for prevention and treatment of dermatitis or functional food composition for increasing immunnity containing medicinal herbs as an effective ingredient |
| CN104587385A (en) * | 2015-01-07 | 2015-05-06 | 辛怡静 | Traditional Chinese medicine composition for treating blood stasis condensation type rosacea |
| CN104623062A (en) * | 2015-02-10 | 2015-05-20 | 济南康众医药科技开发有限公司 | Pharmaceutical composition for treating pimples |
| RU2554766C2 (en) * | 2009-10-02 | 2015-06-27 | Джонсон Энд Джонсон Конзьюмер Компаниз, Инк. | Compositions, containing anti-inflammatory mixture |
| US9289361B2 (en) | 2009-10-02 | 2016-03-22 | Johnson & Johnson Consumer Inc. | Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter |
| US9370474B2 (en) | 2009-10-02 | 2016-06-21 | Johnson & Johnson Consumer Inc. | High-clarity aqueous concentrates of 4-hexylresorcinol |
| US9375395B2 (en) | 2009-10-02 | 2016-06-28 | Johnson & Johnson Consumer Inc. | Compositions comprising an NFκB-inhibitor and a tropoelastin promoter |
| US10307352B2 (en) | 2012-09-24 | 2019-06-04 | Johnson & Johnson Consumer Inc. | Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester |
-
1997
- 1997-09-29 JP JP9281487A patent/JPH11100324A/en active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101302225B1 (en) * | 2007-11-22 | 2013-08-30 | 이규민 | Pharmaceutical Composition for prevention and treatment of dermatitis or functional food composition for increasing immunnity containing medicinal herbs as an effective ingredient |
| US9603789B2 (en) | 2009-08-14 | 2017-03-28 | Amorepacific Corporation | Composition containing a natural extract |
| JP2016041703A (en) * | 2009-08-14 | 2016-03-31 | 株式会社アモーレパシフィックAmorepacific Corporation | Acne sebum production inhibiting composition containing extracts of acanthopanax senticosus |
| JP2013501779A (en) * | 2009-08-14 | 2013-01-17 | 株式会社アモーレパシフィック | Natural extract-containing composition |
| JP2017193560A (en) * | 2009-08-14 | 2017-10-26 | 株式会社アモーレパシフィックAmorepacific Corporation | Sebum production-inhibiting composition comprising saururus chinensis extract |
| RU2554766C2 (en) * | 2009-10-02 | 2015-06-27 | Джонсон Энд Джонсон Конзьюмер Компаниз, Инк. | Compositions, containing anti-inflammatory mixture |
| US9289361B2 (en) | 2009-10-02 | 2016-03-22 | Johnson & Johnson Consumer Inc. | Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter |
| US9370474B2 (en) | 2009-10-02 | 2016-06-21 | Johnson & Johnson Consumer Inc. | High-clarity aqueous concentrates of 4-hexylresorcinol |
| US9375395B2 (en) | 2009-10-02 | 2016-06-28 | Johnson & Johnson Consumer Inc. | Compositions comprising an NFκB-inhibitor and a tropoelastin promoter |
| US9629794B2 (en) | 2009-10-02 | 2017-04-25 | Johnson & Johnson Consumer Inc. | Compositions comprising an NFκB-inhibitor and a tropoelastin promoter |
| US10307352B2 (en) | 2012-09-24 | 2019-06-04 | Johnson & Johnson Consumer Inc. | Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester |
| CN104587385A (en) * | 2015-01-07 | 2015-05-06 | 辛怡静 | Traditional Chinese medicine composition for treating blood stasis condensation type rosacea |
| CN104623062A (en) * | 2015-02-10 | 2015-05-20 | 济南康众医药科技开发有限公司 | Pharmaceutical composition for treating pimples |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08505630A (en) | Pharmaceutical and skin cosmetic compositions containing equine colostrum | |
| CN113924108B (en) | Topical skin care composition comprising centella asiatica | |
| JPH08325135A (en) | Topical skin | |
| US6403654B1 (en) | Compositions for and method of treatment for psoriasis | |
| JP2010502700A (en) | Drugs for treating acne, drugs for recovering symptoms of aging and sunburn, and methods using the same | |
| JP2003238379A (en) | Skin care preparation and hair cosmetic | |
| JPH11100324A (en) | Composition for treating acne | |
| TW201417822A (en) | Topical composition for treating acne | |
| JPH10114648A (en) | External composition for skin | |
| JPH09183718A (en) | Composition suitable for external application | |
| CN111936130A (en) | Topical formulation and method of treatment containing strontium and methylsulfonylmethane (MSM) | |
| JPH11269043A (en) | Cosmetic for scalp and hair | |
| CN112022868A (en) | Anti-hair loss and hair growth uses of gentiopicroside | |
| JP2001288046A (en) | Composition for scalp and hair | |
| JP2004315442A (en) | Gray hair prevention / improvement agent | |
| JPS6322510A (en) | External preparation for skin | |
| JP3819126B2 (en) | Skin preparation for inhibiting sebum synthesis | |
| JPH04305519A (en) | Skin humectant for external use | |
| JPH0429934A (en) | Externally applicable composition containing extracted essence of ginkgo leaf | |
| JPH11302133A (en) | Cosmetic for scalp and hair | |
| JPH10265365A (en) | External preparation for skin for pimple | |
| JP2826142B2 (en) | Dandruff inhibitor composition | |
| JPH11116436A (en) | Preparation for external use for skin | |
| JP2004307372A (en) | External preparation for acne, use of plum extract and germicidal and antibacterial agent | |
| JPH11255621A (en) | Cosmetic for scalp and hair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040419 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071121 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080312 |